| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.028 | 0.3 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | 0.028 | 0.3 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.3 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.032 | 0.3 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.044 | 0.3 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | 0.033 | 0.3 |